NYSE:FMS Fresenius Medical Care AG & Co. KGaA Q3 2026 Earnings Report $22.64 +0.40 (+1.78%) Closing price 10/5/2026 03:59 PM EasternExtended Trading$22.63 -0.02 (-0.07%) As of 08:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Fresenius Medical Care AG & Co. KGaA EPS ResultsActual EPSN/AConsensus EPS $0.61Beat/MissN/AOne Year Ago EPSN/AFresenius Medical Care AG & Co. KGaA Revenue ResultsActual RevenueN/AExpected Revenue$5.65 billionBeat/MissN/AYoY Revenue GrowthN/AFresenius Medical Care AG & Co. KGaA Announcement DetailsQuarterQ3 2026Date11/3/2026TimeBefore Market OpensConference Call DateTuesday, November 3, 2026Conference Call Time8:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Fresenius Medical Care AG & Co. KGaA Earnings HeadlinesBerenberg Bank Downgrades Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to HoldOctober 1, 2026 | americanbankingnews.comHead to Head Comparison: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) versus Auna (NYSE:AUNA)September 25, 2026 | americanbankingnews.comDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.October 6 at 1:00 AM | Porter & Company (Ad)Jefferies Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)August 9, 2026 | theglobeandmail.comBernstein Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)August 9, 2026 | theglobeandmail.comFresenius Medical Care AG 2026 Q2 - Results - Earnings Call PresentationAugust 7, 2026 | seekingalpha.comSee More Fresenius Medical Care AG & Co. KGaA Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fresenius Medical Care AG & Co. KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fresenius Medical Care AG & Co. KGaA and other key companies, straight to your email. Email Address About Fresenius Medical Care AG & Co. KGaAFresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a Germany-based health care company focused on the treatment of chronic kidney disease and kidney failure. The company provides dialysis care through a global network of outpatient clinics and supports patients with related medical services, including vascular access care, laboratory services and care coordination. In addition to operating dialysis facilities, Fresenius Medical Care develops and manufactures products used in dialysis treatment. Its portfolio includes hemodialysis machines, dialyzers, bloodlines, dialysis concentrates, peritoneal dialysis products and other consumables and equipment used by health care providers and patients. Headquartered in Bad Homburg, Germany, Fresenius Medical Care serves patients, clinics and health care systems across multiple geographies, including Europe, North America, Latin America and other international markets. The company was created in 1996 through the combination of Fresenius’s dialysis business and National Medical Care, helping establish an integrated model that combines dialysis products with treatment services.View Fresenius Medical Care AG & Co. KGaA ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 3 Low-Rated Stocks Analysts May Be Underestimating Ahead of Q3 EarningsNVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can RunMarketBeat Week in Review – 09/28 - 10/02Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?Time to Nibble on MCD Stock After it Enters Oversold Territory?Liberty Energy’s AI Power Push Has Wall Street DividedMcCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
